Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) issued this Form 8-K on June 13, 2007, to disclose information regarding upcoming meetings with securities analysts and investors. The primary purpose of these meetings, scheduled between June 13 and June 29, 2007, was to reaffirm the company's ability to meet previously issued earnings expectations. These expectations were originally communicated in a press release and conference call on April 25, 2007. This filing serves as a communication tool under Regulation FD, ensuring that material information is broadly disseminated. Investors should note that this specific disclosure is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it does not automatically incorporate into future SEC filings. The confirmation of earnings guidance is the key takeaway for investors assessing the company's near-term financial outlook.
Key Highlights
- 1Elevance Health (then WellPoint, Inc.) confirmed upcoming meetings with analysts and investors from June 13-29, 2007.
- 2The primary purpose of these meetings was to reaffirm previously issued earnings guidance.
- 3The earnings guidance was originally provided in a press release and conference call on April 25, 2007.
- 4This filing is made under Regulation FD to ensure broad dissemination of information.
- 5The information furnished in this 8-K is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
- 6No new financial results or material changes in business operations were disclosed in this specific filing.